British Journal of Haematology · 2018 · 28 citations · 32 references
MedicineOncologyPathologyCellular PathologyImmunopathologyTumor MicroenvironmentImmune Cell InfiltrationImmunohistochemistryLymphoid NeoplasmsLymphoid Tissue PathologyLymphoid TumorsPlasma Cell NeoplasmsAntibodiesCell InfiltrationClinicopathological CorrelationDiagnostic HistologyLymphocyte SubtypesLymphoma HistopathologyLymphoma MicroenvironmentPlasma Cell Biology
Plasma cells are important prognostic actors in different malignancies. The tumour microenvironmental composition in classic Hodgkin lymphoma (cHL) is a major prognostic key element; however, clinicopathological studies regarding plasma cells in cHL are lacking. The aim of this study was to investigate CD138+ (also termed SDC1+) plasma cell and IgG4 producing (IgG4+) plasma cells infiltration in the microenvironment of cHL. Immunohistochemistry with anti-CD138 and IgG4 antibodies was performed on diagnostic tumour biopsies from 124 patients with cHL, on tissue micro array (TMA). In 120 cases, CD138+ plasma cell-infiltration was associated with the presence of B-symptoms (P = 0·028) and advanced stage, IIB-IVB (P = 0·009). In multivariate analysis, CD138+ plasma cells correlated with eosinophil infiltration (P = 0·013). The subgroup of IgG4+ plasma cells was analysed in 122 cases and only correlated to CD138+ plasma cells (P = 0·004). Patients with high proportion of tumour infiltrating CD138+ plasma cells (defined as ≥10%), had a more inferior event-free survival (P = 0·007) and overall survival (P = 0·004) than patients with a low proportion of infiltrating CD138+ plasma cells (<10%), although significance was not maintained in multivariate analysis. In summary, a high proportion of tumour-associated plasma cells in cHL reflect an important component in the microenvironment of cHL.
32
Report of the Committee on Hodgkin's Disease Staging Classification.
Paul P. Carbone, Henry S. Kaplan, K. Musshoff et al. · PubMed · 1971 · 4.2K citations
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour, Joan Font-Burgada, Giuseppe Di et al. · Nature · 2015 · 594 citations
Medicine, Immunology, Oncology +14
Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells
Hyung W. Lim, Peter Hillsamer, Alison H. Banham et al. · The Journal of Immunology · 2005 · 591 citations
David J. DiLillo, Yasuhito Hamaguchi, Yoshihiro Ueda et al. · The Journal of Immunology · 2008 · 373 citations · Full text
Life Sciences, Immunology, Pathology +16